What is the share price of Anupam Rasayan India Ltd (ANURAS) today?
The share price of ANURAS as on 12th August 2026 is ₹1205.50. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.What is the return on Anupam Rasayan India Ltd (ANURAS) share?
The past returns of Anupam Rasayan India Ltd (ANURAS) share are- Past 1 week: -0.28%
- Past 1 month: -5.12%
- Past 3 months: -11.15%
- Past 6 months: -11.26%
- Past 1 year: 6.27%
- Past 3 years: 27.21%
- Past 5 years: 68.91%
What are the peers or stocks similar to Anupam Rasayan India Ltd (ANURAS)?
The peers or stocks similar to Anupam Rasayan India Ltd (ANURAS) include:What is the dividend yield % of Anupam Rasayan India Ltd (ANURAS) share?
The current dividend yield of Anupam Rasayan India Ltd (ANURAS) is 0.12.What is the market cap of Anupam Rasayan India Ltd (ANURAS) share?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Anupam Rasayan India Ltd (ANURAS) is ₹13767.68 Cr as of 12th August 2026.What is the 52 week high and low of Anupam Rasayan India Ltd (ANURAS) share?
The 52-week high of Anupam Rasayan India Ltd (ANURAS) is ₹1415 and the 52-week low is ₹1045.20.What is the PE and PB ratio of Anupam Rasayan India Ltd (ANURAS) stock?
The P/E (price-to-earnings) ratio of Anupam Rasayan India Ltd (ANURAS) is 80.92. The P/B (price-to-book) ratio is 4.47.Which sector does Anupam Rasayan India Ltd (ANURAS) belong to?
Anupam Rasayan India Ltd (ANURAS) belongs to the Materials sector & Specialty Chemicals sub-sector.How to buy Anupam Rasayan India Ltd (ANURAS) shares?
You can directly buy Anupam Rasayan India Ltd (ANURAS) shares on Tickertape. Simply sign up, connect your demat account and place your order.
Anupam Rasayan India Ltd
ANURAS Share Price
NSE₹1,205.500.31% (-3.80)
High
—
—
Low
—
—
Returns
—
—
1D
1W
1M
1Y
5Y
Max
SIP
1D
1W
1M
1Y
5Y
Max
SIP
ANURAS Stock Scorecard
Performance
LowHasn't fared well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
AvgAverage profitability - not good, not bad
Entry point
AvgThe stock is overpriced but is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
ANURAS Performance & Key Metrics
ANURAS Performance & Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| 80.93 | 4.47 | 0.12% |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 25.25 | 3.22 | 1.37% |
57%
Analysts have suggested that investors can buy this stock
from 7 analysts
Price Upside
Earnings Growth
Rev. Growth
ANURAS Company Profile
Anupam Rasayan is engaged in the business of custom synthesis and manufacturing of specialty chemicals in India.
FLUOROCHEM
PE Ratio
84.52
84.52
1Y Return
28.93%
28.93%
Buy Reco %
73.33
73.33
NAVINFLUOR
PE Ratio
63.06
63.06
1Y Return
69.05%
69.05%
Buy Reco %
78.57
78.57
PE Ratio
98.83
98.83
1Y Return
122.79%
122.79%
Buy Reco %
60.00
60.00
AARTIIND
PE Ratio
43.74
43.74
1Y Return
34.78%
34.78%
Buy Reco %
85.00
85.00
FINEORG
PE Ratio
37.64
37.64
1Y Return
4.72%
4.72%
Buy Reco %
80.00
80.00
ANURAS Sentiment Analysis
ANURAS Sentiment Analysis
New
Crisp summary & key insights to decode earnings calls instantly
ANURAS Stock Summary · May 2026
Strong FY26 growth and an acquisition‑led pivot toward pharma and high‑performance materials was the dominant message, with consolidated revenue rising to INR 2,384 crore and FY26 EBITDA of INR 543 crore (23% margin). Management emphasized a deliberate strategic shift away from agrochemicals into pharma, polymers, personal‑care and semiconductor/EV end markets, building a globally integrated specialty‑chemicals platform that leverages Tanfac for fluorination inputs, Jayhawk’s U.S. manufacturing and Bliss’s formulation accreditations to win multinational customers. The team framed acquisitions as catalytic—Jayhawk adds roughly US$76m in pro‑forma revenue and Bliss brings differentiated formulation and CDMO potential—while noting pro‑forma distortions from recent deals. Tensions discussed included higher gross/net debt (about INR 1,500 crore and net ~INR 1,100 crore, rising toward ~INR 1,400–1,500 crore post‑acquisition), long working‑capital days (~215–220 pro‑forma) and Bliss’s current ~30% utilization that must ramp. Management expects Bliss synergies to begin in 6–12 months and grow by ~18 months, described the Bliss deal as day‑one EPS accretive, and reiterated maintenance capex of ~INR 50–75 crore with regulatory approvals and open‑offer timing of ~2–3 months.
ANURAS Stock Growth Drivers
ANURAS Stock Growth Drivers
6Record FY26 Financial Performance and Strong Cash Conversion
The company delivered its highest-ever revenue in FY26 with consolidated revenue of INR 2,384 crore
Capex Completion and Available Capacity to Support Near‑Term Growth
The final phase of the capex program was completed with INR 315 crore invested, bringing
ANURAS Stock Challenges
ANURAS Stock Challenges
6Profitability and Margin Compression Despite Strong Revenue Growth
Consolidated top-line growth has been strong but profitability metrics have weakened, indicating margin pressure. Q4
Low Capacity Utilization and Capex Timing/Justification Risk
Operations are running well below potential capacity and planned capital expenditure lacks quantified revenue justification,
ANURAS Forecast
ANURAS Forecasts
Price
Revenue
Earnings
ANURAS Share Price Forecast
ANURAS Share Price Forecast
2026
Current
₹1,209.30
Baseline
Forecast for Aug 2027
High
₹—
Median
₹—
Low
₹—
All values in ₹
2026
Current
₹1,209.30
Baseline
Forecast for Aug 2027
High
₹—
Median
₹—
Low
₹—
All values in ₹
ANURAS Company Revenue Forecast
ANURAS Company Revenue Forecast
2026
Current
₹2.38
Baseline
Forecast for Mar 2027
High
₹—
Median
₹—
Low
₹—
All values in ₹ Thousand cr.
2026
Current
₹2.38
Baseline
Forecast for Mar 2027
High
₹—
Median
₹—
Low
₹—
All values in ₹ Thousand cr.
ANURAS Stock EPS (Earnings Per Share) Forecast
ANURAS Stock EPS (Earnings Per Share) Forecast
2026
Current
₹15.09
Baseline
Forecast for Mar 2027
High
₹—
Median
₹—
Low
₹—
All values in ₹
2026
Current
₹15.09
Baseline
Forecast for Mar 2027
High
₹—
Median
₹—
Low
₹—
All values in ₹
ANURAS
ANURAS
Income
Balance Sheet
Cash Flow
Quarterly Normal View
ANURAS Income Statement
ANURAS Income Statement
Quarterly Normal View
| Quarter | dec 2023 | mar 2024 | jun 2024 | sep 2024 | dec 2024 | mar 2025 | jun 2025 | sep 2025 | dec 2025 | mar 2026 | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 297.90 | 413.05 | 260.27 | 295.90 | 386.59 | 505.70 | 490.74 | 739.19 | 514.55 | 639.15 | ||||||||||
Operating & Other expenses | 216.44 | 308.33 | 201.02 | 213.54 | 265.84 | 355.70 | 361.54 | 595.61 | 384.97 | 498.49 | ||||||||||
EBITDA | 81.46 | 104.72 | 59.25 | 82.36 | 120.75 | 150.00 | 129.20 | 143.58 | 129.58 | 140.66 | ||||||||||
| Depreciation/Amortization | 20.43 | 20.75 | 20.65 | 21.68 | 29.30 | 30.66 | 30.68 | 32.07 | 34.47 | 42.68 | ||||||||||
| PBIT | 61.03 | 83.97 | 38.60 | 60.68 | 91.45 | 119.34 | 98.52 | 111.51 | 95.11 | 97.98 | ||||||||||
| Interest & Other Items | 25.13 | 26.07 | 22.38 | 26.66 | 31.96 | 31.22 | 35.67 | 35.98 | 35.16 | 41.91 | ||||||||||
| PBT | 35.90 | 57.90 | 16.22 | 34.02 | 59.49 | 88.12 | 62.85 | 75.53 | 59.95 | 56.07 | ||||||||||
| Taxes & Other Items | 17.49 | 27.00 | 12.31 | 17.35 | 31.31 | 43.54 | 28.81 | 31.14 | 10.90 | 13.43 | ||||||||||
| Net Income | 18.41 | 30.90 | 3.91 | 16.67 | 28.18 | 44.58 | 34.04 | 44.39 | 49.05 | 42.64 | ||||||||||
| EPS | 1.70 | 2.81 | 0.36 | 1.51 | 2.57 | 4.06 | 3.10 | 3.93 | 4.31 | 3.75 |
ANURAS Company Updates
FY 2026FY 2026
Investor Presentation
May 23PDF
May 23PDF
Feb 14PDF
+3 more
ANURAS Stock Peers
ANURAS Past Performance & Peer Comparison
ANURAS Past Performance & Peer Comparison
Comparing 3 stocks from
MaterialsSpecialty Chemicals
Compare valuation on Screener
MaterialsSpecialty Chemicals
Valuation
Technical
Forecast
Compare valuation on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Anupam Rasayan India Ltd | 80.92 | 4.47 | 0.12% |
| Gujarat Fluorochemicals Ltd | 84.52 | 6.65 | 0.07% |
| Navin Fluorine International Ltd | 63.06 | 10.53 | 0.11% |
| Aether Industries Limited | 98.83 | 9.74 | — |
ANURAS Stock Price Comparison
Compare ANURAS with any stock or ETFCompare ANURAS with any stock or ETF
ANURAS
ANURAS Holdings
ANURAS Shareholdings
ANURAS Promoter Holdings Trend
ANURAS Promoter Holdings Trend
Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook
In last 6 months, promoter holding in the company has almost stayed constant
Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better
Pledged promoter holdings is insignificant
ANURAS Institutional Holdings Trend
ANURAS Institutional Holdings Trend
Total Retail Holding
Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.
In last 3 months, retail holding in the company has almost stayed constant
Foreign Institutional Holding
Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock
In last 3 months, foreign institutional holding of the company has almost stayed constant
ANURAS Shareholding Pattern
ANURAS Shareholding Pattern
ANURAS Shareholding History
ANURAS Shareholding History
Foreign Institutions
Mutual Funds Invested in ANURAS
Mutual Funds Invested in ANURAS
No mutual funds holding trends are available
Top 5 Mutual Funds holding Anupam Rasayan India Ltd
| Funds (Top 5) | The rupee value of the stock held by the fund divided by the stock’s market cap Market-cap held | Percentage of the fund’s portfolio invested in the stock Weight | Change in the portfolio weight of the stock over the last 3 months 3M holding change | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months Portfolio rank(3M change) |
|---|---|---|---|---|
The rupee value of the stock held by the fund divided by the stock’s market cap 0.0416% | Percentage of the fund’s portfolio invested in the stock 0.17% | Change in the portfolio weight of the stock over the last 3 months -0.01% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 168/255 (-3) | |
The rupee value of the stock held by the fund divided by the stock’s market cap 0.0213% | Percentage of the fund’s portfolio invested in the stock 1.21% | Change in the portfolio weight of the stock over the last 3 months 1.21% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 43/129 (+2) | |
The rupee value of the stock held by the fund divided by the stock’s market cap 0.0212% | Percentage of the fund’s portfolio invested in the stock 0.17% | Change in the portfolio weight of the stock over the last 3 months -0.01% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 111/254 (-2) |
Compare 3-month MF holding change on Screener
Hmm, looks like there hasn't been any net deal activity in the last 6 monthssmallcases containing ANURAS stock
smallcases containing ANURAS stock
Looks like this stock is not in any smallcase yet.
ANURAS Events
ANURAS Events
ANURAS Dividend Trend
No Trend In Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year
ANURAS has shown inconsistent dividend trend over the last 5 years
Dividend Yield
Dividend return is one of the most important things to be considered while investing for long term. It is the additional return on top of what investors earn through price appreciation
Current dividend yield is 0.12%. An investment of ₹1,000 in the stock is expected to generate dividend of ₹1.20 every year
Dividends
Corp. Actions
Announcements
Legal Orders
Dividends
ANURAS Dividend Trend
No Trend In Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year
ANURAS has shown inconsistent dividend trend over the last 5 years
Dividend Yield
Dividend return is one of the most important things to be considered while investing for long term. It is the additional return on top of what investors earn through price appreciation
Current dividend yield is 0.12%. An investment of ₹1,000 in the stock is expected to generate dividend of ₹1.20 every year
ANURAS Upcoming Dividends
ANURAS Upcoming Dividends
No upcoming dividends are available
ANURAS Past Dividends
ANURAS Past Dividends
Cash Dividend
Ex DateEx DateJul 21, 2025
Interim
Interim | Div/Share: ₹0.75
Dividend/Share
₹0.75
Ex DateEx Date
Jul 21, 2025
Cash Dividend
Ex DateEx DateSep 17, 2024
Final
Final | Div/Share: ₹0.75
Dividend/Share
₹0.75
Ex DateEx Date
Sep 17, 2024
Cash Dividend
Ex DateEx DateNov 20, 2023
Interim 1
Interim 1 | Div/Share: ₹0.50
Dividend/Share
₹0.50
Ex DateEx Date
Nov 20, 2023
Cash Dividend
Ex DateEx DateMay 15, 2023
Interim 3
Interim 3 | Div/Share: ₹1.50
Dividend/Share
₹1.50
Ex DateEx Date
May 15, 2023
Cash Dividend
Ex DateEx DateFeb 8, 2023
Interim 2
Interim 2 | Div/Share: ₹0.60
Dividend/Share
₹0.60
Ex DateEx Date
Feb 8, 2023
ANURAS Stock News & Opinions
ANURAS Stock News & Opinions
Articles & Videos
Corporate
Corporate
Anupam Rasayan India to review financial results at a board meeting on August 14Anupam Rasayan India Limited will hold a board meeting on Friday, August 14, 2026, to consider and approve the unaudited financial results (standalone and consolidated) for the quarter ended June 30, 2026. Trading window for the company's securities was closed from Wednesday, July 01, 2026, and will remain closed until August 16, 2026, in accordance with the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015.
1 day agoCapital Market - Live
Corporate
Corporate
Anupam Rasayan India signs non-binding LoI with BASQUEVOLT, S.A.Anupam Rasayan India announced that it has signed a non-binding Letter of Intent (LOI) with BASQUEVOLT, S.A., a European developer of solid-state lithium batteries, headquartered in Mi'ano (Araba/'lava), Spain. Under the LOI, the parties intend to explore the potential supply of a specialty chemical product over a period of up to 10 years for cumulative revenue of $300 Mn. The LOI is non-binding and preliminary. Any supply would be subject to the successful completion of product development and to the negotiation and signing of a definitive supply agreement.
3 weeks agoCapital Market - Live
Corporate
Corporate
CRISIL places Anupam Rasayan's credit ratings on watchAnupam Rasayan India (ARIL) has received credit ratings for bank facilities (Rs 1620 crore) and non-convertible debentures (Rs 160 crore) at CRISIL A+/ CRISIL A1. These ratings are placed on 'Rating Watch with Developing Implications'. The ratings have been placed on watch following announcement by ARIL of acquisition of 43.3-48.2% equity stake in Bliss GVS Pharma, a pharmaceutical (pharma) formulations company based in India, which may be funded through debt, equity or internal accrual.
2 months agoCapital Market - Live
Corporate
Corporate
Board of Anupam Rasayan India recommends final dividendAnupam Rasayan India announced that the Board of Directors of the Company at its meeting held on 23 May 2026, inter alia, have recommended the final dividend of Rs 1.5 per equity Share (i.e. 15%) , subject to the approval of the shareholders.
2 months agoCapital Market - Live
Earnings
Earnings
Anupam Rasayan India consolidated net profit declines 4.31% in the March 2026 quarterNet profit of Anupam Rasayan India declined 4.31% to Rs 42.65 crore in the quarter ended March 2026 as against Rs 44.57 crore during the previous quarter ended March 2025. Sales rose 27.12% to Rs 635.78 crore in the quarter ended March 2026 as against Rs 500.16 crore during the previous quarter ended March 2025. For the full year,net profit rose 82.24% to Rs 170.12 crore in the year ended March 2026 as against Rs 93.35 crore during the previous year ended March 2025. Sales rose 64.61% to Rs 2365.46 crore in the year ended March 2026 as against Rs 1436.97 crore during the previous year ended March 2025. ParticularsQuarter EndedYear EndedMar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var. Sales635.78500.16 27 2365.461436.97 65 OPM %21.5928.88 -22.1927.90 - PBDT98.75118.77 -17 394.30300.13 31 PBT56.0788.12 -36 254.40197.85 29 NP42.6544.57 -4 170.1293.35 82 Powered by Capital Market - Live
2 months agoCapital Market - Live
Corporate
Corporate
Anupam Rasayan India to convene board meetingAnupam Rasayan India will hold a meeting of the Board of Directors of the Company on 23 May 2026.
2 months agoCapital Market - Live
Earnings
Earnings
Anupam Rasayan India consolidated net profit rises 73.96% in the December 2025 quarterNet profit of Anupam Rasayan India rose 73.96% to Rs 49.04 crore in the quarter ended December 2025 as against Rs 28.19 crore during the previous quarter ended December 2024. Sales rose 31.35% to Rs 512.45 crore in the quarter ended December 2025 as against Rs 390.14 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var. Sales512.45390.14 31 OPM %24.8831.86 - PBDT94.4288.79 6 PBT59.9559.50 1 NP49.0428.19 74 Powered by Capital Market - Live
5 months agoCapital Market - Live
Corporate
Corporate
Anupam Rasayan India to announce Quarterly ResultAnupam Rasayan India will hold a meeting of the Board of Directors of the Company on 14 February 2026.Powered by Capital Market - Live
6 months agoCapital Market - Live
Earnings
Earnings
Anupam Rasayan India consolidated net profit rises 166.29% in the September 2025 quarterNet profit of Anupam Rasayan India rose 166.29% to Rs 44.39 crore in the quarter ended September 2025 as against Rs 16.67 crore during the previous quarter ended September 2024. Sales rose 148.81% to Rs 731.40 crore in the quarter ended September 2025 as against Rs 293.96 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales731.40293.96 149 OPM %18.5727.36 - PBDT107.6155.70 93 PBT75.5434.02 122 NP44.3916.67 166 Powered by Capital Market - Live
9 months agoCapital Market - Live
Spotlight
Spotlight
Anupam Rasayan registers 87% YoY rise in Q2 PAT to Rs 57 croreEBITDA improved by 74% to Rs 143.6 crore in Q2 FY26 from Rs 82.4 crore recorded in Q2 FY25. EBITDA margin in Q2 FY26 was 20% as against 28% in Q2 FY25. Profit before tax in Q2 FY26 stood at Rs 75.5 crore, up by 122% from Rs 34 crore posted in Q2 FY25. Anand Desai, managing director, Anupam Rasayan, said: 'I am delighted to share that Q2 FY26 has been one of the best quarters for our company. For the first half of FY26, consolidated revenue stood at Rs 1,229 crore, registering a robust 122% YoY growth. I am pleased to highlight that within just six months of this financial year, we have already surpassed the total revenue of FY25, demonstrating the resilience of our business model, strong customer relationships, and operational excellence. Our subsidiary, Tanfac Industries, also delivered a strong performance during H1 FY26, reporting revenue of Rs 345 crore, marking a 67% year-on-year growth.' Anupam Rasayan India (ARIL) is one of the leading companies engaged in the custom synthesis (CSM) and manufacturing of specialty chemicals in India. The speciality chemicals major has two verticals: life science related specialty chemicals, which comprise of products related to agrochemicals, personal care and pharmaceuticals, and other specialty chemicals, which comprise of polymer additives. The company caters to a diverse base of Indian and global customers. The scrip declined 3.01% to currently trade at Rs 1093.95 on the BSE. Powered by Capital Market - Live
9 months agoCapital Market - Live
Over the last 5 years, revenue has grown at a yearly rate of 23.27%, vs industry avg of 13.88%
Over the last 5 years, market share increased from 1.61% to 2.16%
Over the last 5 years, net income has grown at a yearly rate of 19.33%, vs industry avg of 20.37%